Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guifu Dihuang / Jingui Shenqi pills for nocturia in kidney yang deficiency
ChiCTR2300069136Phase 4Not yet recruiting
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Mar 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of guifu dihuang pill and Jingui Shenqi pill in Kidney Yang Deficiency (KYD) and nocturia (4 arms), sponsored by Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoint: Nocturia frequency of urination. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
guifu dihuang pillJingui Shenqi pill
03
Conditions
Kidney Yang Deficiency (KYD)nocturia
Beyond the preview
Go deeper on ChiCTR2300069136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069136.